Surgepays, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Surgepays, Inc. (Nasdaq: SURG, SURGW) on February 23, 2024. The filing addresses corporate governance matters, specifically the scheduling of the 2024 Annual Meeting of Stockholders and the deadlines for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance notifications and does not contain financial performance data.
Material Changes
The primary material change disclosed is the Board's determination of the date for the 2024 Annual Meeting of Stockholders. Because this date is scheduled more than 30 days prior to the anniversary of the 2023 annual meeting, the company is providing specific due dates for shareholder actions.
Guidance, Outlook, and Risks
- Annual Meeting Date: The 2024 Annual Meeting is scheduled for Thursday, April 18, 2024. Specific time and website details will be included in the upcoming proxy statement.
- Submission Deadlines: Stockholder proposals under Rule 14a-8 and director nominations under the Company's Bylaws must be received by March 22, 2024.
- Submission Address: Proposals must be sent to the Corporate Secretary at 3124 Brother Blvd, Suite 104, Bartlett, TN 38133.
- Risks and Contingencies: The filing does not disclose new risks, contingencies, or unusual items beyond the standard requirement for proposals to comply with SEC rules and the Company's Bylaws.
Key Facts for Investor Verification
- Verify the exact time and virtual meeting platform details once the proxy statement is filed.
- Confirm the March 22, 2024 deadline for submitting any shareholder proposals or director nominations.
- Note that the filing contains no financial updates; investors should refer to the most recent 10-K or 10-Q for financial status.